Not necessarily this calendar year. MPS VI read out not until November and then PAR will speak to authorities to see if Phase 3 needed. If P3 not needed then asset becomes more valuable. If P3 needed then any upfront payments likely to be used for P3 trials in MPS as per 28 April announcement. So imo MPS deal likely first half of next year but doesn't take away need for capital. Someone mentioned previously needing at least another $100mn to finish KOA trials which I scoffed at. Looking at all the trials in 2024, they could well be right. I'm hoping I'm wrong, but I don't see where we get funding pre 2024 without a capital raise.
Not necessarily this calendar year. MPS VI read out not until...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.010(3.23%) |
Mkt cap ! $104.9M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 29.0¢ | $161.3K | 527.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10756 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 62010 | 3 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |